Clinical trial
A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic…
NCT00495365 · Ortho Biotech Products, L.P., Industry · Terminated
Key facts
| NCT number | NCT00495365 |
|---|---|
| Title | A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease. |
| Official title | Evaluation of Dose Conversion From Variable Dosing Intervals of Darbepoetin Alfa to Variable Dosing Intervals of Epoetin Alfa in Patients With the Anemia of Chronic Kidney Disease |
| Lead sponsor | Ortho Biotech Products, L.P., Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Renal Insufficiency |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 8 |
| Start date | Jun 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Jul 3, 2007 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: